Skip to main navigation
AASLD Family of Websites: The Liver Meeting
AASLD.org AASLD Foundation LiverLearning Careers Journals Liver Fellow Network HCV Guidelines
Home

TLM Main Navigation

  • Claim CE Credits
  • For Industry
    Why Exhibit Reserve a Booth Exhibitor Resources
  • Attend
    Housing Venue Visa Letter
  • Program
    Call for Abstracts Open On-Site Guides
  • Submit an Abstract

Evolving Treatment Paradigms in Hepatocellular Carcinoma

Nov 12 2023
Ballroom BC - Hynes Convention Center
4:30 - 6:00 PM EST

Speakers

Kate Kelley

University of California, San Francisco

Yoshimichi Haruna

Osaka General Medical Center

Rex Wan-Hin Hui

Department of Medicine, School of Clinical Medicine, the University of Hong Kong

I-Cheng Lee

Taipei Veterans General Hospital

Heechul Nam

The Catholic University of Korea

Yosuke Murata

University of Fukui

Description

Abstracts

  • ANTICANCER EFFECTS OF VITAMIN K COMBINED WITH TRANSARTERIAL CHEMOEMBOLIZATION IN HEPATOCELLULAR CARCINOMA; A PROSPECTIVE, RANDOMIZED TRIAL.
  • MOLECULAR SIGNATURE OF PERIPHERAL CIRCULATING TUMOR CELLS IN CANCER PROGRESSION OF HEPATOCELLULAR CARCINOMA PATIENTS TREATED BY ATEZOLIZUMAB PLUS BEVACIZUMAB
  • FOUR-YEAR OVERALL SURVIVAL UPDATE FROM THE PHASE 3 HIMALAYA STUDY OF TREMELIMUMAB PLUS DURVALUMAB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA
  • RECURR-NET, A MULTIPHASIC DEEP LEARNING MODEL, IS SUPERIOR TO MICROVASCULAR INVASION IN PREDICTING HEPATOCELLULAR CARCINOMA RECURRENCE AFTER CURATIVE SURGERY: RESULTS FROM INTERNAL VALIDATION AND EXTERNAL TESTING
  • COMPARISON OF RECURRENCE PREDICTION MODELS AND IMBRAVE 050 CRITERIA TO SELECT PATIENTS FOR ADJUVANT IMMUNOTHERAPY AFTER CURATIVE RESECTION OF HEPATOCELLULAR CARCINOMA
  • ANALYSIS OF IMMUNE-RELATED ADVERSE EVENTS AND TIME-TO-TREATMENT DISCONTINUATION OF ATEZOLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY
About Us
  • AASLD Foundation
  • About AASLD
Legal
  • Abstract Policies
  • Accreditation and Designation Statements
  • Disclosure Policy
  • Embargo Policy
  • Ethics Policy
  • Event Registration Policies
  • Limited License for Use
Get In Touch
  • Contact
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2025 American Association for the Study of Liver Diseases
AASLD: The Liver Meetings - Nov. 15-19, 2024